Status:
COMPLETED
Histology Post-Endoscopic Eradication Therapy (EET)
Lead Sponsor:
Northwestern University
Conditions:
Esophageal Reflux
Barrett Esophagus
Eligibility:
All Genders
18+ years
Brief Summary
This study is looking at a cohort of patients who have undergone treatment for Barrett's Esophagus (BE) and who have experienced complete eradication of the disease. The aim of the proposed study is t...
Eligibility Criteria
Inclusion
- \- Patients who have undergone endoscopic eradication therapy and 24hr pH impedance testing as part of standard of care between 2009 and 2014.
- \- Individuals who have signed a consent to be part of the Prospective Evaluation of Barrett's Esophagus Study population.
Exclusion
- \- Individuals who are not yet adults (infants, children and teenagers), pregnant women and prisoners will be excluded from the study.
- \- Patient who were previously unable or unwilling to give consent to the Prospective Evaluation of Barrett's Esophagus Study will be excluded.
Key Trial Info
Start Date :
August 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 5 2017
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03375060
Start Date
August 2 2017
End Date
November 5 2017
Last Update
December 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611